|
Tuesday, 06 January 2009 |
|
Medical Research News Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. |
|
Read more...
|
|
|
Tuesday, 23 December 2008 |
|
Disease/Infection News One of Malaysia's top politicians has apparently suggested that HIV carriers should not be permitted to marry in order to avoid having sick children. |
|
Read more...
|
|
|
Wednesday, 17 December 2008 |
|
Medical Research News Evolving HIV viral strains and the adverse side effects associated with long-term exposure to recent treatments propel scientists to continue exploring alternative HIV treatments.In a new study, a University of Missouri researcher has identified broad-spectrum aptamers. |
|
Read more...
|
|
|
Wednesday, 17 December 2008 |
|
Disease/Infection News Researchers at Northwestern University have discovered a critical new way a man can transmit the HIV virus to a woman. |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Devices/Technology Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Devices/Technology The Female Health Company has announced that the U.S. Food and Drug Administration's (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted that the company's second-generation female condom, the FC2 Female Condom, is approvable with a single condition. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Disease/Infection News By blocking PD-1 (programmed death-1), an immune receptor molecule known to inhibit the immune response to chronic viral infections, scientists have securely and significantly decreased the plasma viral load and also prolonged survival of rhesus macaque monkeys severely... |
|
Read more...
|
|
|
Tuesday, 09 December 2008 |
|
Medical Science News Cells are filled with membrane-bound organelles like the nucleus, mitochondria and endoplasmic reticula. |
|
Read more...
|
|
|
Friday, 05 December 2008 |
|
Medical Research News To help develop an effective HIV vaccine, researchers are trying to better understand how the immune systems of a little minority of HIV-infected people known as long-term non-progressors (LTNPs) contain the virus naturally. |
|
Read more...
|
|
|
Thursday, 04 December 2008 |
|
Medical Research News A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how 2 major variants of HIV vary in their capability to cause neurologic difficulties. |
|
Read more...
|
|
|
Wednesday, 03 December 2008 |
|
Disease/Infection News Addressing the discrimination against HIV-positive teachers in Africa is a key aim of a new documentary and accompanying book being launched in Senegal today by the Partnership for Child Development based at Imperial College London. |
|
Read more...
|
|
|
Wednesday, 03 December 2008 |
|
Disease/Infection News While the rest of the world acknowledged World AIDS Day this week in many ways, Papua New Guinea (PNG) appears to be struggling to come to terms with the HIV/AIDS epidemic which threatens the population. |
|
Read more...
|
|
|
Tuesday, 02 December 2008 |
|
Drug Trials GeoVax Labs, Inc. has announced that the launch of its Phase 2a Human Vaccine Trials will take place in twelve sites across North and South America.These trials are conducted in collaboration with The National Institutes of Health (NIH), and the HIV Vaccine Trials Network (HVTN). |
|
Read more...
|
|
|
Tuesday, 02 December 2008 |
|
Disease/Infection News On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely support HIV screening to all of their patients older than 13 years.This new practice guideline appears on the Annals of Internal Medicine Web site at www. |
|
Read more...
|
|
|
Tuesday, 02 December 2008 |
|
Disease/Infection News December the 1st 2008 marked the 20th anniversary of World AIDS day - a day when people around the world take stock of the AIDS situation and consider those who have died from the disease and those who are struggling to live with it. |
|
Read more...
|
|
|
Monday, 01 December 2008 |
|
Disease/Infection News Increasing the production of naturally happening proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists. |
|
Read more...
|
|
|
Monday, 01 December 2008 |
|
Disease/Infection News With World AIDS Day on December 1, a leading expert is urging the Government to repeat the 1980s campaigns in order to deal with a new crisis of awareness and understanding of the AIDS threat in the UK. |
|
Read more...
|
|
|
Friday, 28 November 2008 |
|
Drug Trials EpiVax, Inc., a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to optimize delivery of an HIV vaccine. |
|
Read more...
|
|
|
Friday, 28 November 2008 |
|
Disease/Infection News A study published in the British medical journal Lancet yesterday suggesting that testing all adults in Africa annually for HIV and instantly treating every person who tests positive could halt the AIDS epidemic in Africa within a decade has spurred the AIDS Healthcare... |
|
Read more...
|
|
|
Friday, 28 November 2008 |
|
Disease/Infection News AIDS Research Assistance Institute, a non-profit organization, has been monitoring hundreds of people with AIDS/HIV when they add the immunity boosting food supplement, 'concentrated Flax Hull Lignans' (FHL) to their diets. |
|
Read more...
|
|
|
Thursday, 27 November 2008 |
|
Disease/Infection News Universal and yearly voluntary testing followed by instant antiretroviral therapy treatment (irrespective of clinical stage or CD4 count) can decrease new HIV cases by 95% within 10 years, according to new findings based on a mathematical model developed by a group of HIV... |
|
Read more...
|
|
|
Wednesday, 26 November 2008 |
|
Medical Patent News Peregrine Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number No. 7,455,833, which includes broad claims covering anti-viral applications of antibodies that directly bind to aminophospholipids. |
|
Read more...
|
|
|
Wednesday, 26 November 2008 |
|
Pharmaceutical News The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals. |
|
Read more...
|
|
|
Friday, 21 November 2008 |
|
Pharmaceutical News Viral Genetics, Inc. has announced it has completed its acquisition of V-Clip Pharmaceuticals, Inc. ("V-Clip").Viral Genetics has exercised its option to acquire the remaining 56 percent of V-Clip it did not already own. |
|
Read more...
|
|
|
Friday, 21 November 2008 |
|
Drug Trials Testing very young babies for HIV and giving antiretroviral therapy (ART) instantly to those found infected with the virus dramatically prevents sickness and death, according to a report in the New England Journal of Medicine. |
|
Read more...
|
|
|
Wednesday, 19 November 2008 |
|
Miscellaneous News A new partnership between the Indiana University and Kenya's Moi University will develop master's degrees at both universities that focus on ethical issues in international health research. |
|
Read more...
|
|
|
Monday, 17 November 2008 |
|
Disease/Infection News A previously unknown regulatory step during human immunodeficiency (HIV) replication provides a potentially wonderful new goal for HIV/AIDS therapy, report researchers at the Salk Institute for Biological Studies and the University of Wisconsin, Madison. |
|
Read more...
|
|
|
Monday, 17 November 2008 |
|
Medical Research News Scientists have unraveled in unprecedented detail the cascade of events that go wrong in brain cells affected by HIV, a virus whose assault on the nervous system continues unabated in spite of antiviral medications that can keep the virus at bay for years in the rest of the... |
|
Read more...
|
|
|
Thursday, 13 November 2008 |
|
Drug Trials Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online in 2 papers in The Lancet this week. |
|
Read more...
|
|
|
Wednesday, 12 November 2008 |
|
|
|
Read more...
|
|
